{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:50:19Z","timestamp":1789519819993,"version":"build-2803163510"},"reference-count":31,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/or.2016.4985","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T06:37:57Z","timestamp":1469687877000},"page":"2177-2183","source":"Crossref","is-referenced-by-count":49,"title":["miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1"],"prefix":"10.3892","volume":"36","author":[{"given":"Cheng","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,28]]},"reference":[{"key":"key20180107221129_b1-or-36-04-2177","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107221129_b2-or-36-04-2177","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0959-8049(02)00495-1","article-title":"Moderate progress for ovarian cancer in the last 20 years: Prolongation of survival, but no improvement in the cure rate","volume":"38","author":"Engel","year":"2002","journal-title":"Eur J Cancer"},{"key":"key20180107221129_b3-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ajpath.2013.01.039","article-title":"miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin \u03b15 expression","volume":"182","author":"Ohyagi-Hara","year":"2013","journal-title":"Am J Pathol"},{"key":"key20180107221129_b4-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","article-title":"CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells","volume":"154","author":"Lessan","year":"1999","journal-title":"Am J Pathol"},{"key":"key20180107221129_b5-or-36-04-2177","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.1999.5388","article-title":"Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro","volume":"73","author":"Strobel","year":"1999","journal-title":"Gynecol Oncol"},{"key":"key20180107221129_b6-or-36-04-2177","doi-asserted-by":"crossref","first-page":"915140","DOI":"10.1155\/2012\/915140","article-title":"Integrin inhibitors as a therapeutic agent for ovarian cancer","volume":"2012","author":"Sawada","year":"2012","journal-title":"J Oncol"},{"key":"key20180107221129_b7-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/sj.cdd.4401849","article-title":"ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase","volume":"13","author":"Hodkinson","year":"2006","journal-title":"Cell Death Differ"},{"key":"key20180107221129_b8-or-36-04-2177","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107221129_b9-or-36-04-2177","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/iub.200","article-title":"Giving off mixed signals\u2013distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour","volume":"61","author":"Morgan","year":"2009","journal-title":"IUBMB Life"},{"key":"key20180107221129_b10-or-36-04-2177","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2013.00222","article-title":"Tumor targeting via integrin ligands","volume":"3","author":"Marelli","year":"2013","journal-title":"Front Oncol"},{"key":"key20180107221129_b11-or-36-04-2177","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2407-12-359","article-title":"Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites","volume":"12","author":"Wintzell","year":"2012","journal-title":"BMC Cancer"},{"key":"key20180107221129_b12-or-36-04-2177","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1757-2215-5-7","article-title":"Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination","volume":"5","author":"Watanabe","year":"2012","journal-title":"J Ovarian Res"},{"key":"key20180107221129_b13-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107221129_b14-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/jnci\/djt302","article-title":"miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition","volume":"105","author":"Sun","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key20180107221129_b15-or-36-04-2177","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1208\/s12248-010-9194-0","article-title":"microRNA and cancer","volume":"12","author":"Li","year":"2010","journal-title":"AAPS J"},{"key":"key20180107221129_b16-or-36-04-2177","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cas.12395","article-title":"Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway","volume":"105","author":"Yi","year":"2014","journal-title":"Cancer Sci"},{"key":"key20180107221129_b17-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107221129_b18-or-36-04-2177","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107221129_b19-or-36-04-2177","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1023777013659","article-title":"The role of integrin-linked kinase (ILK) in cancer progression","volume":"22","author":"Persad","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107221129_b20-or-36-04-2177","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc1524","article-title":"Integrin-linked kinase: A cancer therapeutic target unique among its ILK","volume":"5","author":"Hannigan","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107221129_b21-or-36-04-2177","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1476-5381.2011.01581.x","article-title":"Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting \u03b15\u03b21 integrin to down-regulate Akt and MMP-2","volume":"165","author":"Peng","year":"2012","journal-title":"Br J Pharmacol"},{"key":"key20180107221129_b22-or-36-04-2177","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6601576","article-title":"Integrins: Roles in cancer development and as treatment targets","volume":"90","author":"Jin","year":"2004","journal-title":"Br J Cancer"},{"key":"key20180107221129_b23-or-36-04-2177","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov"},{"key":"key20180107221129_b24-or-36-04-2177","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3476(87)80504-8","article-title":"Growth after renal transplantation in children","volume":"110","author":"Fine","year":"1987","journal-title":"J Pediatr"},{"key":"key20180107221129_b25-or-36-04-2177","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/onc.2009.201","article-title":"Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers","volume":"28","author":"Ebi","year":"2009","journal-title":"Oncogene"},{"key":"key20180107221129_b26-or-36-04-2177","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.febslet.2014.04.036","article-title":"miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells","volume":"588","author":"Wu","year":"2014","journal-title":"FEBS Lett"},{"key":"key20180107221129_b27-or-36-04-2177","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/iub.1051","article-title":"MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells","volume":"64","author":"Wei","year":"2012","journal-title":"IUBMB Life"},{"key":"key20180107221129_b28-or-36-04-2177","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2014.01.061","article-title":"miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression","volume":"444","author":"Gao","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107221129_b29-or-36-04-2177","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ncomms2276","article-title":"Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130","volume":"3","author":"Ma","year":"2012","journal-title":"Nat Commun"},{"key":"key20180107221129_b30-or-36-04-2177","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/onc.2012.52","article-title":"Role of MMP-2 in the regulation of IL-6\/Stat3 survival signaling via interaction with \u03b15\u03b21 integrin in glioma","volume":"32","author":"Kesanakurti","year":"2013","journal-title":"Oncogene"},{"key":"key20180107221129_b31-or-36-04-2177","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2010.12.362","article-title":"A phase II, single-arm study of the anti-\u03b15\u03b21 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer","volume":"121","author":"Bell-McGuinn","year":"2011","journal-title":"Gynecol Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4985\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:12:54Z","timestamp":1515345174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,28]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,7,28]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/or.2016.4985"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4985","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,28]]}}}